Aerobic Gram-positive cocci: Staphylococcus aureus and Staphylococcus epidermidis (both penicillinase-producing and non-penicillinase-producing strains), Streptococci (except Enterococcus faecalis), Pneumococci. Anaerobic Gram-negative rods: Bacteroides (including Bacteroides fragilis and melanin-producing Bacteroides) and Fusobacterium. Anaerobic Gram-positive non-spore-producing rods: Propionibacterium, Eubacterium and Actinomyces. Anaerobic and microaerophilic Gram-positive rods: Peptococcus, microaerophilic Streptococcus and Peptostreptococcus.

No specific description provided

No specific description provided

This product is a highly selective 5HT3 receptor antagonist, which has a good preventive and therapeutic effect on nausea and vomiting caused by radiotherapy, chemotherapy and surgery. It inhibits the occurrence of nausea and vomiting by antagonizing the 5HT3 receptors in the central chemoreceptor area and peripheral vagus nerve endings. This product has high selectivity and no side effects such as extrapyramidal reactions and excessive sedation.

This product is an H2 receptor antagonist. It has an inhibitory effect on the secretion of gastric acid and pepsin. Patients with gastric and duodenal ulcers were given this product at a dose of 20 mg twice a day for 1-2 months, and there was no effect on the gastrin level in the blood. Normal people and patients with peptic ulcers were given this product at a dose of 20 mg twice a day for 4 weeks, and there was no effect on the levels of prolactin, gonadotropin and sex hormones in the blood.